Poultry Bacterial Disease Vaccines Market Size to Reach USD 3.30 Billion by 2034

According to a report by IntelMarketResearch, the global Poultry Bacterial Disease Vaccines Market was valued at USD 2.02 billion in 2025 and is projected to grow from USD 2.15 billion in 2026 to USD 3.30 billion by 2034, registering a CAGR of 7.0% during the forecast period. Poultry bacterial disease vaccines are veterinary biological products designed to prevent and control bacterial infections including Salmonella, Pasteurella and Escherichia coli in chickens and turkeys.

Explore the full report: https://www.intelmarketresearch.com/poultry-bacterial-disease-vaccines-market-market-36431

Why Is Demand Increasing?

Intensive poultry production: Large-scale commercial poultry farming is increasing the need for preventive disease management.
Biosecurity requirements: Stronger disease-control programs are supporting routine vaccination.
Antibiotic-free production: Consumer and industry interest in reducing antibiotic use is encouraging preventive vaccination.
Disease outbreaks: Salmonellosis, colibacillosis and other bacterial diseases create significant production risks.
Advanced vaccine platforms: Recombinant-vector and DNA-based technologies are expanding product development.

Poultry Health & Preventive Veterinary Care Watch

Vaccination is becoming an increasingly important component of poultry health-management programs. Live and attenuated vaccines continue to represent important product categories, while recombinant, DNA-based and thermostable technologies are being developed to improve protection and reduce cold-chain requirements.

Segmentation Highlights

By Type: Live Vaccines, Attenuated Vaccines and Killed Vaccines.
By Application: Salmonella Prevention, Pasteurella Control, E. coli Management and Other Bacterial Diseases.
By End User: Commercial Poultry Farms, Hatcheries and Veterinary Clinics.
By Administration Method: Injection, Oral and Drinking Water.
By Disease Prevalence: High, Moderate and Low Prevalence Regions.
By Region: Asia-Pacific, North America, Europe and other major poultry markets.

Regional Outlook

Asia-Pacific: Identified as the largest market in 2025, supported by intensive poultry production and expanding vaccination programs.
North America: Established commercial poultry operations and veterinary infrastructure support demand.
Europe: Food-safety standards and biosecurity requirements contribute to adoption.
Global market: The study provides regional and country-level market analysis.

Download the free sample report: https://www.intelmarketresearch.com/download-free-sample/36431/poultry-bacterial-disease-vaccines-market-market

Why This Market Matters

Poultry bacterial disease vaccines support preventive disease management and can help commercial producers reduce losses associated with bacterial infections. Drinking-water administration is particularly relevant for large-scale operations because it allows mass vaccination with reduced handling requirements.

The market is also developing through thermostable formulations and multivalent vaccine platforms that may reduce cold-chain dependence and provide broader pathogen coverage.

Competitive Landscape

Key companies profiled include Merck Animal Health, Zoetis, Boehringer Ingelheim, Ceva Santé Animale, Vaxxinova, Elanco, QYH Biotech, Pulike Biological Engineering, Phibro Animal Health, JinYu Biotechnology, Harbin Pharmaceutical Group, MEVAC, Venky's, Japfa Comfeed Indonesia and Nisseiken.

View the full report: https://www.intelmarketresearch.com/poultry-bacterial-disease-vaccines-market-market-36431

FAQ

Q: What is the Poultry Bacterial Disease Vaccines Market size?
A: The market was valued at USD 2.02 billion in 2025 and is projected to reach USD 3.30 billion by 2034 at a CAGR of 7.0%.

Q: What diseases are covered?
A: Major applications include prevention and control of Salmonella, Pasteurella and E. coli, along with other bacterial diseases.

Q: What is driving demand?
A: Intensive poultry production, biosecurity requirements, disease risks and demand for antibiotic-free protein are major factors.

What Does the Full Report Cover?

The complete report provides global and regional market sizing, forecasts, vaccine-type segmentation, disease/application analysis, administration-method assessment, competitive analysis and market dynamics.

The study examines live, attenuated and killed vaccines and evaluates their use across commercial poultry farms, hatcheries and veterinary clinics. It also assesses emerging recombinant, DNA-based and thermostable vaccine technologies.

View the complete report: https://www.intelmarketresearch.com/poultry-bacterial-disease-vaccines-market-market-36431

Download the free sample: https://www.intelmarketresearch.com/download-free-sample/36431/poultry-bacterial-disease-vaccines-market-market

About IntelMarketResearch

IntelMarketResearch provides market intelligence, industry analysis, competitive research, forecasting and customized research support across global markets.